UY31923A - Nuevos heterociclos para su uso como inhibidores de trombina - Google Patents

Nuevos heterociclos para su uso como inhibidores de trombina

Info

Publication number
UY31923A
UY31923A UY0001031923A UY31923A UY31923A UY 31923 A UY31923 A UY 31923A UY 0001031923 A UY0001031923 A UY 0001031923A UY 31923 A UY31923 A UY 31923A UY 31923 A UY31923 A UY 31923A
Authority
UY
Uruguay
Prior art keywords
heterocicles
new
thrombin inhibitors
trypsin
medicaments
Prior art date
Application number
UY0001031923A
Other languages
English (en)
Inventor
Magnus Polla
Gustafsson David
Nilsson Ingemar
Branalt Jonas
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY31923A publication Critical patent/UY31923A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Esta invención se relaciona con nuevos compuestos farmacéuticamente útiles de la fórmula I en particular compuestos que son inhibidores competitivos de las serina proteasa similares a la tripsina, especialmente la trombina, su uso como medicamentos, las composiciones farmacéuticas que los contienen y las rutas sintéticas para su producción.
UY0001031923A 2008-06-23 2009-06-22 Nuevos heterociclos para su uso como inhibidores de trombina UY31923A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7473608P 2008-06-23 2008-06-23
US10238108P 2008-10-03 2008-10-03

Publications (1)

Publication Number Publication Date
UY31923A true UY31923A (es) 2010-01-29

Family

ID=41431868

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031923A UY31923A (es) 2008-06-23 2009-06-22 Nuevos heterociclos para su uso como inhibidores de trombina

Country Status (20)

Country Link
US (2) US20110130432A1 (es)
EP (1) EP2321301A4 (es)
JP (1) JP2011525487A (es)
KR (1) KR20110025970A (es)
CN (1) CN102131802A (es)
AR (1) AR072278A1 (es)
AU (1) AU2009263076B2 (es)
BR (1) BRPI0914323A2 (es)
CA (1) CA2727925A1 (es)
CO (1) CO6321275A2 (es)
CR (1) CR11873A (es)
DO (1) DOP2010000402A (es)
EA (1) EA018502B1 (es)
EC (1) ECSP10010710A (es)
IL (1) IL210076A0 (es)
MX (1) MX2010014229A (es)
TW (1) TW201002689A (es)
UY (1) UY31923A (es)
WO (1) WO2009157860A1 (es)
ZA (1) ZA201100568B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354444B2 (en) 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
RU2570896C2 (ru) * 2013-04-23 2015-12-20 Общество с ограниченной ответственностью "Химико-фармацевтические технологии" (ООО "ХимФармТех") (4-фтор-бензил)-этил-(2-тетразол-1-ил-фенил)-амин и способ его получения
CN104610184A (zh) * 2015-01-13 2015-05-13 佛山市赛维斯医药科技有限公司 苯二烯四氮唑类化合物、其制备方法和用途
CN104529923B (zh) * 2015-01-13 2016-06-01 佛山市赛维斯医药科技有限公司 二烯四氮唑硝基苯类化合物、其制备方法和用途
EP3672939A1 (en) 2017-08-21 2020-07-01 Celgene Corporation Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
CN113636982A (zh) * 2021-04-28 2021-11-12 合肥工业大学 一种肉桂酸衍生物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
EP0820453A4 (en) * 1995-04-04 2001-08-29 Merck & Co Inc THROMBIN INHIBITORS
AR013084A1 (es) * 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
ATE268750T1 (de) 1997-08-28 2004-06-15 Biovitrum Ab Proteintyrosinphosphatase inhibitoren
EP1051431A1 (de) * 1998-01-26 2000-11-15 Basf Aktiengesellschaft Thrombininhibitoren
US6482921B1 (en) 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
FR2793248B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE0001803D0 (sv) * 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
WO2002050056A1 (en) * 2000-12-18 2002-06-27 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en) * 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
US7144899B2 (en) * 2001-02-09 2006-12-05 Merck & Co., Inc. Thrombin inhibitors
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
AU2003299901A1 (en) * 2002-10-04 2004-05-04 Merck And Co., Inc. Thrombin inhibitors
GB0327761D0 (en) 2003-11-29 2003-12-31 Astrazeneca Ab Compounds
NZ577312A (en) 2006-12-06 2012-02-24 Sanofi Aventis Urea and sulfamide derivatives as tafia inhibitors
WO2009004383A2 (en) 2007-07-03 2009-01-08 Astrazeneca Ab Aza-bicyclohexane compounds useful as anticoagulants
PT2300462E (pt) 2008-06-06 2014-08-05 Sanofi Sa Derivados macrocíclicos de ureia e de sulfamidas como inibidores de tafia

Also Published As

Publication number Publication date
CA2727925A1 (en) 2009-12-30
US20110130432A1 (en) 2011-06-02
WO2009157860A1 (en) 2009-12-30
EP2321301A1 (en) 2011-05-18
JP2011525487A (ja) 2011-09-22
ZA201100568B (en) 2012-06-27
TW201002689A (en) 2010-01-16
AU2009263076B2 (en) 2012-07-26
DOP2010000402A (es) 2011-01-15
IL210076A0 (en) 2011-02-28
EA018502B1 (ru) 2013-08-30
US8119673B2 (en) 2012-02-21
AR072278A1 (es) 2010-08-18
CR11873A (es) 2011-02-28
EA201001823A1 (ru) 2011-06-30
CN102131802A (zh) 2011-07-20
ECSP10010710A (es) 2011-01-31
AU2009263076A1 (en) 2009-12-30
US20090318517A1 (en) 2009-12-24
EP2321301A4 (en) 2011-09-28
BRPI0914323A2 (pt) 2017-03-28
KR20110025970A (ko) 2011-03-14
MX2010014229A (es) 2011-06-20
CO6321275A2 (es) 2011-09-20

Similar Documents

Publication Publication Date Title
UY31203A1 (es) Nuevos compuestos de aza-biciclohexano útiles como inhibidores de trombina
CO6362015A2 (es) Derivados de acido 1-amino-2ciclobutiletilboronico
CR11659A (es) Inhibidores de hsp90
DOP2010000191A (es) Derivados bis-(sulfonilamino)
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
CR11373A (es) COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
CO6680683A2 (es) Inhibiddores de la prostaglandina e2 sintasa-1 microsómica (mpges-1) y composiciones que los contienen, útiles en el tratamiento de enfermedades inflamatorias
UY33779A (es) ?2-(fenilamino)-1H-bencimidazol-5-carboxamidas novedosas?
ECSP10010246A (es) Inhibidores de beta-lactamasa
ECSP10010710A (es) Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina
UY30858A1 (es) Nuevos derivados de fenil-(4-fenil-pirimidin-2-il)- aminas, su preparacion, como medicamentos, composiciones farmacéuticas y especialmente como inhibidores de ikk
CU23840B1 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
UY30748A1 (es) Compuesto0s novedosos
BR112012019042A2 (pt) "inibidores de serina protease tipo tripsina, e sua preparação e uso".
UY29325A1 (es) Nuevos derivados de 2 - amino-piridina
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
UY31299A1 (es) Nuevos inhibidores de catepsina y su uso
CU23944B1 (es) Amidas del ácido pirrolidin-1,2-dicarboxílico sustituidas como moduladores de calicreína 7
CL2011002911A1 (es) Compuestos derivados de benzamidas, inhibidores de serina proteasa; composición farmacéutica; uso del compuesto para tratar cáncer.
UY32635A (es) Derivados de bis-(sulfonilamino) en terapia 735
UY32954A (es) PIRIMIDINAS SUSTITUIDAS CON ADAMANTILIMINOCARBONILO COMO INHIBIDORES DE 11-ß-HSD1 826?.
UY30865A1 (es) Nuevos analogos de piridina x 161
UY29804A1 (es) Quinolinas de alquilnitrilo
UY30457A1 (es) Nuevos compuestos de piridina, composiciones farmacéuticas que los contienen y aplicaciones.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181106